With the World Immunization Week coming up, IFA has produced a study to deliver critical baseline data to help inform technical guidelines, as well as governmental and civil society dialogue and policy actions, to protect the health of LTC residents.

Accurate health-care burden data in healthy infants are necessary to determine RSV immunisation policy when RSV immunisation becomes available.

It provides an overview of the project results at the end of 2 years of collaborative work: the training tools and resources designed to support health professionals in their vaccine communication efforts and the advocacy campaigns.

The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses and the development of new variant-derived vaccines.

Main outcome of the ESWI summit “Pandemic Preparedness: Where Science and Policy Meet”, which took place in Brussels in June 2022, was recently published in the scientific journal One Health Outlook.

In 2022, the annual Atlas took a deeper look into the impact of type 2 diabetes in indigenous peoples, type 1 diabetes across all age groups, COVID-19 among people with diabetes, and diabetes foot-related complications.

Expect the unexpected. This adage flawlessly embodies infectious diseases and pathogens. The causative agents of infectious diseasesmaster the art of exploiting any shortcoming, any breach, any loophole in our defensive arsenal.

Pandemic Action Network releases a policy paper with a set of recommendations to establish ​​a new equitable, effective, and efficient pandemic countermeasures platform that will be key in responding to future health threats.

H5N1 avian influenza viruses of the A/goose/Guangdong/1/96 lineage have been circulating in wild birds for many years, have inflicted significant economic losses on the poultry industry and have caused zoonotic infections since 1997.

Analysis and interpretation of data released by the Chinese Center for Disease Control

Is it possible to improve the antibodies that the body produces to fight SARS-CoV2? In a study led by researchers from Lund University in Sweden, this was investigated by redesigning antibodies and combining them against the virus.

The strategy, presented by the European Commission on 30 November 2022, puts global health forward as an essential pillar of EU external policy